New York State Common Retirement Fund
ALXO icon

New York State Common Retirement Fund’s ALX Oncology ALXO Stock Holding History

New York State Common Retirement Fund’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.5K Buy
+33,100
New +$59.2K ﹤0.01% 2869
2025
Q2 		– Sell
-12,522
Closed -$7.8K – 3205
2025
Q1 		$7.8K Hold
12,522
– – ﹤0.01% 3099
2024
Q4 		$20.9K Hold
12,522
– – ﹤0.01% 3028
2024
Q3 		$22.8K Hold
12,522
– – ﹤0.01% 3026
2024
Q2 		$75.5K Sell
12,522
-124
-1% -$1.52K ﹤0.01% 2974
2024
Q1 		$141K Buy
12,646
+159
+1% +$2.23K ﹤0.01% 2604
2023
Q4 		$186K Sell
12,487
-431
-3% -$4.09K ﹤0.01% 2489
2023
Q3 		$62K Buy
12,918
+58
+0.5% +$315 ﹤0.01% 2943
2023
Q2 		$96.6K Sell
12,860
-23
-0.2% -$151 ﹤0.01% 2868
2023
Q1 		$58.2K Hold
12,883
– – ﹤0.01% 2953
2022
Q4 		$145K Sell
12,883
-11
-0.1% -$124 ﹤0.01% 2857
2022
Q3 		$123K Buy
12,894
+74
+0.6% +$863 ﹤0.01% 2949
2022
Q2 		$104K Sell
12,820
-30
-0.2% -$327 ﹤0.01% 3038
2022
Q1 		$217K Buy
12,850
+13
+0.1% +$222 ﹤0.01% 2794
2021
Q4 		$276K Sell
12,837
-15,362
-54% -$663K ﹤0.01% 2749
2021
Q3 		$2.08M Sell
28,199
-17
-0.1% -$1.13K ﹤0.01% 1745
2021
Q2 		$1.54M Buy
28,216
+4,405
+18% +$264K ﹤0.01% 2023
2021
Q1 		$1.76M Buy
23,811
+5,800
+32% +$456K ﹤0.01% 1855
2020
Q4 		$1.55M Buy
18,011
+13,611
+309% +$819K ﹤0.01% 1810
2020
Q3 		$166K Buy
+4,400
New +$173K ﹤0.01% 2723

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

New York State Common Retirement Fund's ALXO Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in ALX Oncology (ALXO) in Q2 2026: 33,100 shares worth $68.5K. The stake represents ﹤0.01% of the portfolio and ranks #2869 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in ALXO as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in ALXO in Q3 2020 and has held it in 20 quarters since. The position peaked at $2.08M in Q3 2021. 93 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • New York State Common Retirement Fund held 33,100 shares of ALX Oncology worth $68.5K as of Q2 2026.
  • ALX Oncology was a new New York State Common Retirement Fund position in Q2 2026.
  • ALX Oncology made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2869 holding.
  • New York State Common Retirement Fund first reported a position in ALX Oncology in Q3 2020 and has held it in 20 quarters since.
  • New York State Common Retirement Fund's ALX Oncology position peaked at $2.08M in Q3 2021.
  • 93 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.